Eric J. Messner
23Patents
12h-index
10Co-inventors
78Inventor score
Filing activity: Apr 7, 1976 → Apr 22, 2021
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US4153512A | Storage stable antibiotic susceptibility test kit and method of testing | Chemistry; Metallurgy | 65 | Expired |
| US8207149B2 | Method for treating secondary hyperparathyroidism in CKD | Human Necessities | 31 | Active |
| US8361488B2 | Methods and compositions for controlled release oral dosage of a vitamin D compound | Human Necessities | 29 | Active |
| US8426391B2 | Treating vitamin D insufficiency and deficiency with 25-hydroxyvitamin D2 and 25-hydroxyvitamin D3 | Human Necessities | 28 | Active |
| US8778373B2 | Methods for controlled release oral dosage of a vitamin D compound | Human Necessities | 25 | Active |
| US8906410B2 | Oral dosage form of 25-hydroxyvitamin D | Human Necessities | 25 | Active |
| US8592401B2 | Methods and compounds for vitamin D therapy | Human Necessities | 18 | Active |
| US8329677B2 | Method of treating and preventing secondary hyperparathyroidism | Human Necessities | 18 | Active |
| US9408858B2 | Method for treating secondary hyperparathyroidism in CKD | Human Necessities | 17 | Active |
| US9498486B1 | Method for controlled release oral dosage of a vitamin D compound | Human Necessities | 16 | Active |
| US9402855B2 | Method of treating and preventing secondary hyperparathyroidism | Human Necessities | 16 | Active |
| US9913852B2 | Method of treating and preventing secondary hyperparathyroidism | Human Necessities | 15 | Active |
| US9918940B2 | Methods for controlled release oral dosage of a vitamin D compound | Human Necessities | 8 | Active |
| US9943530B2 | Treating vitamin D insufficiency and deficiency with 25-hydroxyvitamin D2 and 25-hydroxyvitamin D3 | Human Necessities | 7 | Active |
| US10668089B2 | Method of treating and preventing secondary hyperparathyroidism | Human Necessities | 0 | Active |
| US10213442B2 | Treating vitamin D insufficiency and deficiency with 25-hydroxyvitamin D2 and 25-hydroxyvitamin D3 | Human Necessities | 0 | Active |
| US11154509B2 | Methods for controlled release oral dosage of a vitamin D compound | Human Necessities | 0 | Active |
| US9925147B2 | Method for treating secondary hyperparathyroidism in CKD | Human Necessities | 0 | Active |
| US11452734B2 | Method of treating and preventing secondary hyperparathyroidism | Human Necessities | 0 | Active |
| US11672809B2 | Methods and compositions for reducing parathyroid levels | Human Necessities | 0 | Active |
| US11801253B2 | Method of safely and effectively treating and preventing secondary hyperparathyroidism in chronic kidney disease | Human Necessities | 0 | Active |
| US11911398B2 | Treating Vitamin D insufficiency and deficiency with 25-hydroxyvitamin D2 and 25-hydroxyvitamin D3 | Human Necessities | 0 | Active |
| US11007204B2 | Treating vitamin D insufficiency and deficiency with 25-hydroxyvitamin D2 and 25-hydroxyvitamin D3 | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.